Publish date:

Glancy Prongay & Murray LLP Announces Proposed Class Action Settlement On Behalf Of Purchasers Of Apyx Medical Corporation Securities -- APYX

TAMPA, Fla., August 24, 2020 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that the United States District Court for the Middle District of Florida has approved the following announcement of a proposed class action settlement that would benefit...

TAMPA, Fla., August 24, 2020 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that the United States District Court for the Middle District of Florida has approved the following announcement of a proposed class action settlement that would benefit purchasers of Apyx Medical Corporation Securities (APYX) - Get Apyx Medical Corporation Report:

SUMMARY NOTICE OF (I) PENDENCY OF CLASS ACTION, CERTIFICATION OF SETTLEMENT CLASS, AND PROPOSED SETTLEMENT; (II) SETTLEMENT HEARING; AND (III) MOTION FOR AN AWARD OF ATTORNEYS' FEES AND REIMBURSEMENT OF LITIGATION EXPENSES

TO:  All persons and entities who, between December 21, 2018 and April 1, 2019, inclusive, purchased or otherwise acquired Apyx Medical Corporation ("Apyx") Common Stock or Apyx Call Options, or wrote Apyx Put Options, and were damaged thereby (the "Settlement Class"):

PLEASE READ THIS NOTICE CAREFULLY, YOUR RIGHTS WILL BE AFFECTED BY A CLASS ACTION LAWSUIT PENDING IN THIS COURT.

YOU ARE HEREBY NOTIFIED, pursuant to Rule 23 of the Federal Rules of Civil Procedure and an Order of the United States District Court for the Middle District of Florida, that the above-captioned litigation (the "Action") has been certified as a class action on behalf of the Settlement Class, except for certain persons and entities who are excluded from the Settlement Class by definition as set forth in the full Notice of (I) Pendency of Class Action, Certification of Settlement Class, and Proposed Settlement; (II) Settlement Hearing; and (III) Motion for an Award of Attorneys' Fees and Reimbursement of Litigation Expenses (the "Notice").

YOU ARE ALSO NOTIFIED that Plaintiffs in the Action have reached a proposed settlement of the Action for $3,000,000 in cash (the "Settlement"), that, if approved, will resolve all claims in the Action.

A hearing will be held on November 6, 2020 at 9:00 a.m., before the Honorable Susan C. Bucklew at the United States District Court for the Middle District of Florida, Sam M. Gibbons United States Courthouse, Courtroom 10B, 801 North Florida Avenue, Tampa, FL 33602, to determine (i) whether the proposed Settlement should be approved as fair, reasonable, and adequate; (ii) whether the Action should be dismissed with prejudice against Defendants, and the Releases specified and described in the Stipulation and Agreement of Settlement dated July 9, 2020 (and in the Notice) should be granted; (iii) whether the proposed Plan of Allocation should be approved as fair and reasonable; and (iv) whether Lead Counsel's application for an award of attorneys' fees and reimbursement of expenses should be approved.  Please note that, in light of the COVID-19 pandemic, the Court may hold the Settlement Hearing telephonically, or change the date, time or location of the hearing.  Please check the settlement website, www.ApyxSecuritiesSettlement.com, for information concerning any such changes. 

If you are a member of the Settlement Class, your rights will be affected by the pending Action and the Settlement, and you may be entitled to share in the Settlement Fund.  The Notice and Proof of Claim and Release Form ("Claim Form"), can be downloaded from the website maintained by the Claims Administrator, www.ApyxSecuritiesSettlement.com .  You may also obtain copies of the Notice and Claim Form by contacting the Claims Administrator at Pritchard v. Apyx Medical Corp., et al., c/o Strategic Claims Services, P.O. Box 230, 600 N. Jackson St., Suite 205, Media, PA 19063, 1-866-274-4004.

If you are a member of the Settlement Class, in order to be eligible to receive a payment under the proposed Settlement, you must submit a Claim Form either online or postmarked no later than December 16, 2020.  If you are a Settlement Class Member and do not submit a proper Claim Form, you will not be eligible to share in the distribution of the net proceeds of the Settlement, but you will nevertheless be bound by any judgments or orders entered by the Court in the Action.

If you are a member of the Settlement Class and wish to exclude yourself from the Settlement Class, you must submit a request for exclusion such that it is received no later than October 16, 2020, in accordance with the instructions set forth in the Notice.  If you properly exclude yourself from the Settlement Class, you will not be bound by any judgments or orders entered by the Court in the Action and you will not be eligible to share in the proceeds of the Settlement.

Any objections to the proposed Settlement, the proposed Plan of Allocation, or Lead Counsel's motion for attorneys' fees and reimbursement of expenses, must be filed with the Court and delivered to Lead Counsel and Defendants' Counsel such that they are received no later than October 16, 2020, in accordance with the instructions set forth in the Notice.

Please do not contact the Court, the Clerk's office, Apyx, or its counsel regarding this notice.  All questions about this notice, the proposed Settlement, or your eligibility to participate in the Settlement should be directed to Lead Counsel or the Claims Administrator.

Requests for the Notice and Claim Form should be made to: Pritchard v. Apyx Medical Corp., et al.    c/o Strategic Claims ServicesP.O. Box 230600 N. Jackson St., Suite 205 Media, PA 19063866-274-4004 www.ApyxSecuritiesSettlement.com

Inquiries, other than requests for the Notice and Claim Form, should be made to Lead Counsel: GLANCY PRONGAY & MURRAY LLP Casey Sadler, Esq.1925 Century Park East, Suite 2100 Los Angeles, CA 90067(888) 773-9224 settlements@glancylaw.com

By Order of the Court

View original content: http://www.prnewswire.com/news-releases/glancy-prongay--murray-llp-announces-proposed-class-action-settlement-on-behalf-of-purchasers-of-apyx-medical-corporation-securities----apyx-301103371.html

SOURCE Glancy Prongay & Murray LLP